Abiraterone acetate for the treatment of metastatic, castrate-resistant prostate cancer following previous cytotoxic chemotherapy
Connock M, Cummins E, Shyangdan D, Hall B, Grove A, Clarke A
Record ID 32011001608
English
Details
Project Status:
Completed
URL for project:
https://www.journalslibrary.nihr.ac.uk/programmes/hta/1015401/#/
Year Published:
2012
URL for published report:
https://www.journalslibrary.nihr.ac.uk/programmes/hta/1015401/#/
Requestor:
NIHR Health Technology Assessment programme
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England, United Kingdom
MeSH Terms
- Androstenols
- Androstenes
- Prostatic Neoplasms
- Enzyme Inhibitors
- Abiraterone Acetate
- Prostatic Neoplasms, Castration-Resistant
- Androgen Antagonists
- Antineoplastic Agents
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.